Redcare Pharmacy NV (SAEYY)
OTCMKTS
· Delayed Price · Currency is USD
12.83
-0.56 (-4.18%)
At close: Apr 4, 2025
Redcare Pharmacy NV Revenue
In the year 2024, Redcare Pharmacy NV had annual revenue of 2.37B EUR with 31.79% growth. Redcare Pharmacy NV had revenue of 675.14M in the quarter ending December 31, 2024, with 27.07% growth.
Revenue
2.37B EUR
Revenue Growth
+31.79%
P/S Ratio
1.17
Revenue / Employee
1.30M EUR
Employees
1,827
Market Cap
2.88B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.37B | 571.82M | 31.79% |
| Dec 31, 2023 | 1.80B | 594.41M | 49.35% |
| Dec 31, 2022 | 1.20B | 144.03M | 13.58% |
| Dec 31, 2021 | 1.06B | 92.26M | 9.53% |
| Dec 31, 2020 | 968.06M | 267.05M | 38.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 301.83M |